A new study reveals that menstrual blood could potentially be used to detect cervical cancer in women. Researchers have found that the genetic material in menstrual blood can indicate the presence of cervical cancer cells. This discovery could lead to a non-invasive and easily accessible method for early detection of cervical cancer, which is the fourth most common cancer in women globally. The study, conducted by scientists at the Indian Institute of Technology (IIT) Gandhinagar, opens up new possibilities for early diagnosis and treatment of this deadly disease. Cervical cancer is highly preventable and curable if detected early, making this finding a significant breakthrough in the field of women’s health. The researchers believe that this new method could revolutionize cervical cancer screening in India, where access to healthcare services is limited in many regions. By using menstrual blood as a diagnostic tool, women could potentially undergo screening for cervical cancer more regularly and conveniently. This could lead to earlier detection of the disease, resulting in better treatment outcomes and ultimately saving lives. The study has been published in the International Journal of Cancer and has already garnered significant attention from the medical community. Further research is needed to validate these findings and potentially implement this new screening method in clinical practice.